Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

Cash to Debt 0.80
MJN's Cash to Debt is ranked higher than
77% of the 1518 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.41 vs. MJN: 0.80 )
MJN' s 10-Year Cash to Debt Range
Min: 0.2   Max: No Debt
Current: 0.8

Equity to Asset 0.14
MJN's Equity to Asset is ranked lower than
59% of the 1518 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.53 vs. MJN: 0.14 )
MJN' s 10-Year Equity to Asset Range
Min: -1.03   Max: 0.49
Current: 0.14

Interest Coverage 16.93
MJN's Interest Coverage is ranked higher than
67% of the 976 Companies
in the Global Packaged Foods industry.

( Industry Median: 15.22 vs. MJN: 16.93 )
MJN' s 10-Year Interest Coverage Range
Min: 7.7   Max: 9999.99
Current: 16.93

F-Score: 6
Z-Score: 6.99
M-Score: -2.51
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

Operating margin (%) 23.08
MJN's Operating margin (%) is ranked higher than
96% of the 1529 Companies
in the Global Packaged Foods industry.

( Industry Median: 6.04 vs. MJN: 23.08 )
MJN' s 10-Year Operating margin (%) Range
Min: 21.05   Max: 42.55
Current: 23.08

Net-margin (%) 15.53
MJN's Net-margin (%) is ranked higher than
94% of the 1530 Companies
in the Global Packaged Foods industry.

( Industry Median: 4.16 vs. MJN: 15.53 )
MJN' s 10-Year Net-margin (%) Range
Min: 13.67   Max: 26
Current: 15.53

ROE (%) 189.69
MJN's ROE (%) is ranked higher than
100% of the 1521 Companies
in the Global Packaged Foods industry.

( Industry Median: 8.29 vs. MJN: 189.69 )
MJN' s 10-Year ROE (%) Range
Min: 69.46   Max: 418.36
Current: 189.69

ROA (%) 18.70
MJN's ROA (%) is ranked higher than
98% of the 1535 Companies
in the Global Packaged Foods industry.

( Industry Median: 4.09 vs. MJN: 18.70 )
MJN' s 10-Year ROA (%) Range
Min: 19.3   Max: 47.17
Current: 18.7

ROC (Joel Greenblatt) (%) 117.26
MJN's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 1533 Companies
in the Global Packaged Foods industry.

( Industry Median: 13.61 vs. MJN: 117.26 )
MJN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 124.17   Max: 252.05
Current: 117.26

Revenue Growth (%) 10.40
MJN's Revenue Growth (%) is ranked higher than
84% of the 1353 Companies
in the Global Packaged Foods industry.

( Industry Median: 5.30 vs. MJN: 10.40 )
MJN' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 10.7
Current: 10.4

EBITDA Growth (%) 11.10
MJN's EBITDA Growth (%) is ranked higher than
84% of the 1204 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.20 vs. MJN: 11.10 )
MJN' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 11.1
Current: 11.1

EPS Growth (%) 13.10
MJN's EPS Growth (%) is ranked higher than
83% of the 1075 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.50 vs. MJN: 13.10 )
MJN' s 10-Year EPS Growth (%) Range
Min: 0   Max: 14.2
Current: 13.1

» MJN's 10-Y Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MJN Guru Trades in Q3 2013

Louis Moore Bacon 290,000 sh (+52.63%)
Manning & Napier Advisors, Inc 674,310 sh (+7.72%)
Eric Mindich 1,106,000 sh (unchged)
George Soros 148,920 sh (unchged)
Ray Dalio Sold Out
John Paulson Sold Out
Paul Tudor Jones Sold Out
Steve Mandel 6,629,859 sh (-10.5%)
Jim Simons 1,037,700 sh (-21.09%)
Robert Karr 1,371,900 sh (-22.36%)
Mario Gabelli 178,702 sh (-24.13%)
MS Global Franchise Fund 79,331 sh (-29.58%)
Steven Cohen 230,365 sh (-32.66%)
Jeremy Grantham 38,853 sh (-82.34%)
» More
Q4 2013

MJN Guru Trades in Q4 2013

Bill Frels 4,922 sh (New)
Ray Dalio 17,200 sh (New)
Joel Greenblatt 9,546 sh (New)
Paul Tudor Jones 54,200 sh (New)
Jeremy Grantham 79,210 sh (+103.87%)
Robert Karr 1,751,900 sh (+27.7%)
Eric Mindich 1,106,000 sh (unchged)
George Soros Sold Out
Louis Moore Bacon Sold Out
Mario Gabelli 176,502 sh (-1.23%)
Manning & Napier Advisors, Inc 641,455 sh (-4.87%)
MS Global Franchise Fund 75,419 sh (-4.93%)
Steven Cohen 184,747 sh (-19.8%)
Jim Simons 622,700 sh (-39.99%)
Steve Mandel 3,560,693 sh (-46.29%)
» More
Q1 2014

MJN Guru Trades in Q1 2014

David Rolfe 2,315,336 sh (New)
Pioneer Investments 467,343 sh (New)
Manning & Napier Advisors, Inc 3,024,603 sh (+371.52%)
Eric Mindich 1,257,100 sh (+13.66%)
Ray Dalio Sold Out
Steve Mandel Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 173,917 sh (-1.46%)
Jeremy Grantham 48,400 sh (-38.9%)
Paul Tudor Jones 31,230 sh (-42.38%)
Jim Simons 353,000 sh (-43.31%)
Bill Frels 2,622 sh (-46.73%)
MS Global Franchise Fund 33,951 sh (-54.98%)
Robert Karr 451,270 sh (-74.24%)
Steven Cohen 19,076 sh (-89.67%)
» More
Q2 2014

MJN Guru Trades in Q2 2014

Joel Greenblatt 5,758 sh (New)
George Soros 34,100 sh (New)
Louis Moore Bacon 44,000 sh (New)
Jim Simons 667,600 sh (+89.12%)
Pioneer Investments 675,179 sh (+44.47%)
David Rolfe 2,381,845 sh (+2.87%)
Robert Karr 459,900 sh (+1.91%)
Bill Frels Sold Out
Paul Tudor Jones Sold Out
Eric Mindich Sold Out
MS Global Franchise Fund 31,957 sh (-5.87%)
Mario Gabelli 162,982 sh (-6.29%)
Jeremy Grantham 43,300 sh (-10.54%)
Manning & Napier Advisors, Inc 835,200 sh (-72.39%)
» More
» Details

Insider Trades

Latest Guru Trades with MJN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Robert Karr 2014-06-30 Add 1.91%0.12%$82.2 - $93.32 $ 103.3918%459900
George Soros 2014-06-30 New Buy0.02%$82.2 - $93.32 $ 103.3918%34100
Joel Greenblatt 2014-06-30 New Buy0.01%$82.2 - $93.32 $ 103.3918%5758
Robert Karr 2014-03-31 Reduce -74.24%7.42%$73.66 - $84.26 $ 103.3928%451270
Steve Mandel 2014-03-31 Sold Out 1.3%$73.66 - $84.26 $ 103.3928%0
Joel Greenblatt 2014-03-31 Sold Out 0.02%$73.66 - $84.26 $ 103.3928%0
Ray Dalio 2014-03-31 Sold Out 0.01%$73.66 - $84.26 $ 103.3928%0
Robert Karr 2013-12-31 Add 27.7%2.17%$74.04 - $85.58 $ 103.3927%1751900
Steve Mandel 2013-12-31 Reduce -46.29%1.02%$74.04 - $85.58 $ 103.3927%3560693
George Soros 2013-12-31 Sold Out 0.12%$74.04 - $85.58 $ 103.3927%0
Joel Greenblatt 2013-12-31 New Buy0.02%$74.04 - $85.58 $ 103.3927%9546
Ray Dalio 2013-12-31 New Buy0.01%$74.04 - $85.58 $ 103.3927%17200
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Mead Johnson Nutrition Co

David Rolfe Comments on Mead Johnson Nutrition - Apr 18, 2014

Mead Johnson Nutrition (MJN)

Edward Mead Johnson: founder of not one, but two great companies in his lifetime. Now, how many of us can say that?! In 1885, after graduating from the University of Michigan with a degree in law, he and his two brothers, Robert Wood Johnson I and James Wood Johnson, would found Johnson & Johnson, the consumer healthcare products company in Brunswick, New Jersey. With no lack of success, Edward soon 15 decided he wanted to do more. Ten short years later, he broke off from Johnson & Johnson and founded American Ferment Company in Jersey City, N.J., making nutritional products. Fast forward another ten years, in 1905 American Ferment re-­‐ established itself as Mead Johnson and Company and the +100 year history of the Mead Johnson Nutrition Company begins. While Mead Johnson's name has remained intact throughout its history, the company – with sales then of $131 million – was acquired in 1967 by Bristol-­‐Myers for $240 million. Bristol-­‐Myers Squibb owned Mead Johnson as a wholly owned subsidiary for the next four decades until they announced in April 2008 plans to sell 10-­‐20% of Mead Johnson to the public through an IPO in order to better focus on its burgeoning biopharmaceutical business. Bristol-­‐Myers Squibb would proceed to split off Mead Johnson and by February 2009 the IPO was complete. Shortly thereafter, in November of 2009, Bristol-­‐Myers would spin out the rest of their ownership of Mead Johnson in a stock swap, valued at $7.7 billion. Mead Johnson Nutrition would operate as a fully independent public company going forward.

Edward Mead Johnson's decision to break away from Johnson and Johnson stemmed from a personal experience that also drove a strong desire to work on nutritionals, primarily in digestive aids. In 1888, Johnson's first child was born, sadly enough, with a feeding disorder and congenital heart defect that required Johnson to prepare a physician-­‐directed product to feed the child. This was a time in history where, in some U.S. cities, up to 30% of infants died before reaching their first birthday (cdc.gov) with leading causes attributed to gastrointestinal disorders and infant digestive problems. Needless to say, Johnson had much motivation. In 1911, the company launched its first infant feeding nutritional product, Dextri Maltose, a carbohydrate powder mixed with milk. It went on to be the first clinically supported, physician-­‐recommended (not to mention the company's best-­‐selling) infant feeding product in the U.S. This product laid the foundation for Mead Johnson's later flagship infant nutritional product, Enfamil.

During World War I, the company could no longer import potato starch (Dextri Maltose's source of carbohydrate) from Germany and was forced to relocate to America's breadbasket where they could have access to an alternate supply of carbohydrates. The company settled in Evansville, Indiana where they found ample supplies of corn, their new source of carbohydrates. Today, the company maintains its Global Operations Center in Evansville. (As an aside, a friend of the firm has its own ties to Mead Johnson via Dextri Maltose and their move to Evansville. After relocating to Evansville, Mead Johnson had difficulty with the production of their best-­‐selling product. Mead Johnson teamed up with George Koch Sons, Inc. who provided packaging containers for Dextri Maltose. Mead Johnson would go on to use Koch packaging exclusively for nearly two decades.)

Over the coming decades, Mead Johnson produced numerous nutritional science breakthroughs. Casec, its first milk-­‐derived product, was introduced in the 1920's to assist gastrointestinal disorders and infant digestive problems – two of the leading causes of death in infants in the United States at the time. According to the 16 National Institute of Health, two-­‐thirds of American children in the early 1900's suffered from rickets – a disorder caused by a lack of vitamin D, calcium, and phosphate, and leads to softening and weakening of bones. Mead Johnson found that cod liver oil provided a source of vitamin D and the company introduced a product that allowed doctors to administer a standardized dose of the supplement. In 1931, the Company introduced the processed (dry and precooked) infant cereal Pablum. The considerable success of Pablum was due to its ease of preparation. Pablum was easily tolerable for infants, and it contained considerable amount of vitamins and minerals. Pablum was sold to H. J. Heinz in 2005.

Mead Johnson introduced its reconstructed milk, Recolac and Powdered Lactid Acid Half Skim Milk in the mid-­‐1920's. Reconstructed milk breaks cow's milk into its major nutritional components and reassembles them, along with other ingredients, into combinations thought to be more appropriate for infant feeding. Olac was later introduced which used vegetable oils rather than animal fats as a fat component.

Sobee Powder was one of the company's initial products, developed shortly after Recolac. This was the first powder produced by Mead Johnson that offered soybean flour as a source of protein for children allergic to the protein in cow's milk. Nearly two decades later, the company developed Mutramigen, the first protein hydrolysate formula in the U.S. for infants with cow's milk protein allergies. This product was a breakthrough in nutrition and remains today one of Mead Johnson's most important products. ProSobee, introduced in the 1960's, was the first infant formula in the U.S. with soy protein isolated from whole soy flour.

Mead Johnson introduced its first baby formula in 1911 and over the century expanded into vitamins, pharmaceutical products, and prenatal nutrition. Enfamil, undoubtedly the brand most recognized today in the United States, was first introduced in the 1950's in both powder form and concentrated liquid. Enfamil was the first routine infant formula patterned after the nutritional composition of human milk. Throughout the years, Enfamil underwent several modifications to improve the formulation in order to keep up with the advancement of science and pediatric nutrition.

Today, the Company's Enfamil brand is recognized worldwide for its leadership in pediatric nutrition. In 1978, a major manufacturer of infant formula (and competitor of Mead Johnson) reformulated two of its soy products, resulting in infant formula products that contained inadequate amount of chloride, an essential nutrient for growth and development in infants. By mid-­‐1979, a substantial number of infants were diagnosed with a syndrome associated with chloride deficiency. What soon followed was a criminal investigation by the U.S. Department of Justice, but more importantly, the passage of the Infant Formula Act of 1980 and its subsequent amendments in 1986. The Act established provisions for current good manufacturing practices (CGMP), quality control, nutrient requirements, and quality factors indicating that infant formulas marketed in the United States should be safe and contain all of the nutrients required to support infant growth and health.

During the legislative history of the Act, one Senator stated why infant formula needs more regulation than other foods: "…there is simply no margin for error in the production of baby formula. An infant relies on the formula to sustain life and provide the proper nourishment at a time of rapid physical and mental development" (fda.gov). The regulations have directly resulted in decreased competition in the industry.

The Company has developed numerous other infant and children's nutritional formulas and supplements. Also found on their list of achievements, Mead Johnson developed products that aid in the treatment for respiratory problems as well as the first weight loss product. For those readers who are over the age of, say 60, may remember the unintended pop culture phenomenon of the Company's weight-­‐loss product Metrecal. Metrecal was essentially this country's first diet protein shake that actually worked. Launched in late 1959, Metrecal was first a powder made up of corn oil, soybean flour and powdered skim milk, plus the powder was loaded with vitamins, minerals and protein. Mixed with water, Metrecal was a 900 calorie-­‐per-­‐day daily diet plan that literally worked wonders. (How could it not when consuming just 900 calories per day?!) A year later the Company introduced Metrecal in a pre-­‐mixed liquid can. As Metrecal moved from the pharmacy, to the kitchen, then on to the nation's patios in the early 1960's, the country's diet craze was in full swing – even Bergdorf Goodman made a high society purse flask that "could be the solution for every secret Metrecal drinker."

So successful was Metrecal that the Company formed an exclusive division (the Edward Dalton Company) for its production and marketing. The Company would proceed to rollout Metrecal milkshakes, Metrecal clam chowder, Metrecal cookies and Metrecal noodles and tuna. By 1965, the Metrecal franchise peaked and would lose its dominance in the 1970's to other crash-­‐diet products – particularly Slim-­‐Fast. By the late 1970's, due to a rash of deaths, the FDA pulled Metrecal and many similar products off the market.

Today, the company's worldwide recognition equates to over 70 products in more than 50 markets leading to a global share of 14% in the infant formula market – a #2 ranking. Mead Johnson International was formed in the mid-­‐1950's to provide a framework for conducting business overseas. Its first Mexican manufacturing facility was built in Mexico City, which today is the site of the company's Latin American regional headquarters. In the 1960's Mead Johnson constructed manufacturing facilities in the Philippines to support their growing presence in Asia. In the 1980's the company expanded into Western Europe, initially offering nutrition products for infants and older babies. Expansion into Central and Eastern Europe soon followed. Over the years, Mead Johnson would continue to develop and introduce formulas in different markets internationally.

Mead Johnson Nutrition Company has three reportable segments – Asia, Latin America, and North America/Europe – which comprised 52%, 20%, and 28% respectively of net sales for the calendar year. In total, 77% of the company's net 18 sales were generated in countries outside the United States. The Asia-­‐Pacific region, alone will likely account for 50% of future global growth. We have identified several drivers of the growth in these regions. In late 2013, China announced it would loosen its one-­‐child policy, allowing couples to have two children so long as one of the parents is an only child. By our estimates, this could expand the total addressable market for pediatric nutrition by a few billion dollars per annum. In addition, the 2008 milk and infant formula scandal has had a long-­‐lasting and material impact on the Chinese infant formula market. Melamine, a toxic chemical used in milk products to artificially boost protein, sickened an estimated 300,000 children. More than 50,000 children were hospitalized and six died from kidney damage. As a result of this scandal, Western brands garnered preferred trust and premium pricing as China, plus other regions, continue to lack the availability of high quality children's nutrition and a mature food supply. We are also seeing a demographic shift of more women in the work force, which will likely increase the use of infant formula and children's nutrition.

Mead Johnson Nutrition has more than a century of research and development, resulting in superior quality, consumer loyalty and leading profitability. As the strict regulations outlined above detail, the FDA scrutinizes the quality of infant formula, creating significant barriers to entry, particularly in the United States. As such, there are three brand-­‐name infant formula manufacturers that control over 80% market share in the U.S., Mead Johnson included. Further, the Company's R&D efforts have led to products with tangible, scientifically proven benefits to newborns, which is a proven differentiator relative to competing products and substitutes (e.g. breast feeding). For instance, outside of the U.S., Mead Johnson boasts the first formula, EFSA-­‐approved (i.e. Europe's FDA) Nutramigen LIPIL, which has proven benefits for visual development superior to those offered by breast milk.

While Mead Johnson has exceptional fundamental characteristics, our process dictates that the stock exhibit a valuation that is just as compelling. We have been following the Company since 2010, and have waited patiently for the stock to trade at the lower end of its valuation range, relative to other investment opportunities. During the quarter, sensible valuation levels came to pass, mostly due to a pullback in shares on near-­‐term concerns about earnings growth, as well as a paucity of cheap investment alternatives. However, we continue to believe that Mead Johnson has an exceptional value proposition that is capable of generating double digit EPS growth through a combination of price increases, share gains and cost containment. As a result of this attractive relative valuation and fundamental outlook, we initiated a new position in Mead Johnson.

From David Rolfe (Trades, Portfolio)'s Wedgewood Partners first quarter 2014 commentary.

Check out David Rolfe latest stock trades

Top Ranked Articles about Mead Johnson Nutrition Co

David Rolfe Comments on Mead Johnson Nutrition
Mead Johnson Nutrition (MJN)


P/E(ttm) 29.40
MJN's P/E(ttm) is ranked higher than
63% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 22.00 vs. MJN: 29.40 )
MJN' s 10-Year P/E(ttm) Range
Min: 12.5   Max: 33.58
Current: 29.4

P/B 41.03
MJN's P/B is ranked lower than
66% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.92 vs. MJN: 41.03 )
MJN' s 10-Year P/B Range
Min: 37.36   Max: 877.33
Current: 41.03

P/S 4.79
MJN's P/S is ranked lower than
62% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.08 vs. MJN: 4.79 )
MJN' s 10-Year P/S Range
Min: 1.59   Max: 4.79
Current: 4.79

PFCF 36.66
MJN's PFCF is ranked higher than
69% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 60.50 vs. MJN: 36.66 )
MJN' s 10-Year PFCF Range
Min: 12.28   Max: 50.57
Current: 36.66

EV-to-EBIT 20.98
MJN's EV-to-EBIT is ranked higher than
70% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 18.47 vs. MJN: 20.98 )
MJN' s 10-Year EV-to-EBIT Range
Min: 9.5   Max: 23
Current: 20.98

PEG 3.66
MJN's PEG is ranked higher than
87% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 9999.00 vs. MJN: 3.66 )
MJN' s 10-Year PEG Range
Min: 1.87   Max: 6.21
Current: 3.66

Shiller P/E 37.21
MJN's Shiller P/E is ranked higher than
70% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 47.20 vs. MJN: 37.21 )
MJN' s 10-Year Shiller P/E Range
Min: 26.25   Max: 34.64
Current: 37.21

Current Ratio 1.89
MJN's Current Ratio is ranked higher than
69% of the 1527 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.62 vs. MJN: 1.89 )
MJN' s 10-Year Current Ratio Range
Min: 0.29   Max: 1.89
Current: 1.89

Quick Ratio 1.44
MJN's Quick Ratio is ranked higher than
76% of the 1527 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.04 vs. MJN: 1.44 )
MJN' s 10-Year Quick Ratio Range
Min: 0.15   Max: 1.44
Current: 1.44


Dividend & Buy Back

Dividend Yield 1.42
MJN's Dividend Yield is ranked lower than
61% of the 1159 Companies
in the Global Packaged Foods industry.

( Industry Median: 1.90 vs. MJN: 1.42 )
MJN' s 10-Year Dividend Yield Range
Min: 0.5   Max: 1.87
Current: 1.42

Dividend Payout 0.44
MJN's Dividend Payout is ranked higher than
74% of the 1630 Companies
in the Global Packaged Foods industry.

( Industry Median: 0.79 vs. MJN: 0.44 )
MJN' s 10-Year Dividend Payout Range
Min: 0.3   Max: 0.64
Current: 0.44

Dividend growth (3y) 14.80
MJN's Dividend growth (3y) is ranked higher than
88% of the 892 Companies
in the Global Packaged Foods industry.

( Industry Median: 3.30 vs. MJN: 14.80 )
MJN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 26
Current: 14.8

Yield on cost (5-Year) 3.66
MJN's Yield on cost (5-Year) is ranked higher than
74% of the 1184 Companies
in the Global Packaged Foods industry.

( Industry Median: 2.10 vs. MJN: 3.66 )
MJN' s 10-Year Yield on cost (5-Year) Range
Min: 1.31   Max: 4.89
Current: 3.66

Share Buyback Rate 0.30
MJN's Share Buyback Rate is ranked higher than
82% of the 954 Companies
in the Global Packaged Foods industry.

( Industry Median: -0.30 vs. MJN: 0.30 )
MJN' s 10-Year Share Buyback Rate Range
Min: 0   Max: -6.4
Current: 0.3

Valuation & Return

Earnings Yield (Greenblatt) 4.80
MJN's Earnings Yield (Greenblatt) is ranked higher than
60% of the 1329 Companies
in the Global Packaged Foods industry.

( Industry Median: 6.70 vs. MJN: 4.80 )
MJN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.3   Max: 10.5
Current: 4.8

Forward Rate of Return (Yacktman) 10.59
MJN's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 1158 Companies
in the Global Packaged Foods industry.

( Industry Median: 5.73 vs. MJN: 10.59 )
MJN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.9   Max: 14.3
Current: 10.59


Business Description

Industry: Consumer Packaged Goods » Packaged Foods
Compare: » details
Traded in other countries:0MJA.Germany
Mead Johnson Nutrition Company, a Delaware corporation, was founded in 1905. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Mead Johnson Nutrition Company has a broad product portfolio, which extends across routine and specialty infant formulas, children's milks and milk modifiers, pediatric vitamins, dietary supplements for pregnant and breastfeeding mothers, and products for metabolic disorders. The Company's comprehensive product portfolio addresses a broad range of nutritional needs for infants, children and expectant and nursing mothers. The Company has over 100 years of innovation experience during which it has developed or improved many breakthrough or industry-defining products across each of its product categories. The Company's singular focus on pediatric nutrition and its implementation of a business model that integrates nutritional science with health care and consumer marketing expertise differentiate it from many of its competitors. The Company markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe. Its two reportable segments are Asia/Latin America and North America/Europe, which comprised 70% and 30%, respectively, of its net sales for the year ended December 31, 2012. The Company designs routine infant formula as a breast milk substitute for healthy, full-term infants without special nutritional needs both for use as the infant's sole source of nutrition and as a supplement to breastfeeding. It endeavors to develop routine infant formula closer to breast milk. It also provides products within its routine formula line for healthy full-term infants who experience common feeding problems with symptoms such as mild spit-up, fussiness or gas. The Company also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers, including Expecta LIPIL and EnfaMama A+. Its products for expectant or nursing mothers provide the developing fetus or breastfed infant with vitamin supplements and/or an increased supply of DHA for brain, visual and nervous system development. These products also supplement the mother's diet by providing either DHA or ARA with increased proteins, as well as 24 vitamins and minerals. The Company competes in two primary categories, infant formula and children's nutrition. The Company is subject to numerous governmental regulations, and it can be costly to comply with these regulations.
» More Articles for MJN


Articles On GuruFocus.com
Hedge Fund Managers Greenblatt and Soros Are Betting On Mead Johnson Nutrition Oct 20 2014 
Investors Should Remain Cautious While Buying Mead Johnson Nutrition Jun 23 2014 
David Rolfe Comments on Mead Johnson Nutrition Apr 18 2014 
Guru Robert Karr Closes Fund Joho Capital - His Top Five Q4 Stocks Feb 17 2014 
Joho's Robert Karr Trims Top Holdings Nov 22 2013 
Investing in Generation Y and the Next Great Baby Boom Nov 16 2013 
Simplicity Rules – Joho Capital’s Top Six Aug 01 2013 
Online Media Investor and Tiger Cub Robert Karr Buys 2 New Stocks Apr 16 2013 
Feeding the Baby Boom in Emerging Markets: Mead Johnson Nutrition Feb 10 2013 
Joho Capital Gives In to Yelp’s Dip, as Competition for the Tech Stock Lies Ahead Dec 18 2012 

More From Other Websites
Mead Johnson Tops Q3 Earnings & Revenues, Retains View Oct 23 2014
Mead Johnson Reaffirms Full-Year EPS Guidance; Third Quarter Revenue Rises Four Percent and... Oct 23 2014
Mead Johnson Nutrition Co Earnings Call scheduled for 9:30 am ET today Oct 23 2014
[$$] Mead Johnson Nutrition Profit Rises 9.5% Oct 23 2014
Mead Johnson beats Street 3Q forecasts Oct 23 2014
Mead Johnson beats Street 3Q forecasts Oct 23 2014
MEAD JOHNSON NUTRITION CO Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 23 2014
7:36 am Mead Johnson Nutrition beats by $0.03, reports revs in-line; guides FY14 EPS in-line Oct 23 2014
Mead Johnson Reaffirms Full-Year EPS Guidance; Third Quarter Revenue Rises Four Percent and... Oct 23 2014
Q3 2014 Mead Johnson Nutrition Co Earnings Release - Before Market Open Oct 23 2014
Mead Johnson Announces Expansion of Production Capacity in Evansville Oct 22 2014
Will Mead Johnson (MJN) Surprise Q3 Earnings Estimates? Oct 21 2014
Mead Johnson Announces Expansion of Production Capacity in Evansville Oct 21 2014
After weeks of volatile trading, major averages move steadily higher Oct 20 2014
Mead Johnson Nutrition downgraded by Deutsche Bank Oct 20 2014
Mead Johnson Nutrition (MJN) Is Today's Unusual Social Activity Stock Oct 20 2014
Why Mead Johnson (MJN) Stock Is Falling Today Oct 20 2014
Hedge Fund Managers Greenblatt and Soros Are Betting On Mead Johnson Nutrition Oct 20 2014
IBM sinks on earnings miss; Apple gains ahead of results Oct 20 2014
BUZZ-U.S. Stocks on the Move-IBM, Halliburton, Family Dollar, Hasbro Oct 20 2014

Personalized Checklist

Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial